Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients

Psychoneuroendocrinology

Volumn 31, Issue 8, 2006, Pages 1019-1025

  Schüle, Cornelius ^a   Zill, Peter ^a   Baghai, Thomas C ^a   Eser, Daniela ^a   Zwanzger, Peter ^a   Wenig, Nadine ^a   Rupprecht, Rainer ^a   Bondy, Brigitta ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

BDNF; Brain derived neurotrophic factor; Depressive disorder; Dexamethasone CRH test; Hypothalamic pituitary adrenocorticol system; Val66Met polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DEXAMETHASONE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; AMINO ACID SUBSTITUTION; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; GENOTYPE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES;

EID: 33746631745     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2006.06.002     Document Type: Article

References (32)

1. Altar C.A. Neurotrophins and depression. Trends Pharmacol. Sci. 20 (1999) 59-61
2. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., and Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry 59 (2006) 812-815
3. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., and Lee F.S. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 24 (2004) 4401-4411
4. Duman R.S. Synaptic plasticity and mood disorders. Mol. Psychiatry 7 Suppl 1 (2002) S29-S34
5. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., and Weinberger D.R. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
6. Franklin T.B., and Perrot-Sinal T.S. Sex and ovarian steroids modulate brain-derived neurotrophic factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions. Psychoneuroendocrinology 31 (2006) 38-48
7. Givalois L., Naert G., Rage F., Ixart G., Arancibia S., and Tapia-Arancibia L. A single brain-derived neurotrophic factor injection modifies hypothalamo-pituitary-adrenocortical axis activity in adult male rats. Mol. Cell. Neurosci. 27 (2004) 280-295
8. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
9. Handa R.J., Burgess L.H., Kerr J.E., and O'Keefe J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 28 (1994) 464-476
10. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., and Weinberger D.R. Brain-derived neurotrophic factor Val66Met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23 (2003) 6690-6694
11. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
12. Künzel H.E., Binder E.B., Nickel T., Ising M., Fuchs B., Majer M., Pfennig A., Ernst G., Kern N., Schmid D.A., Uhr M., Holsboer F., and Modell S. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28 (2003) 2169-2178
13. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P., Thakur M., McEwen B.S., Hauger R.L., and Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1 (1998) 69-73
14. MacLullich A.M., Deary I.J., Starr J.M., Ferguson K.J., Wardlaw J.M., and Seckl J.R. Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology 30 (2005) 505-515
15. Magiakou M.A., Mastorakos G., Webster E., and Chrousos G.P. The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann. N. Y. Acad. Sci. 816 (1997) 42-56
16. Naert G., Ixart G., Tapia-Arancibia L., and Givalois L. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats. Neuroscience 139 (2006) 779-789
17. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., and Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 71 (2002) 651-655
18. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., and Weinberger D.R. The brain-derived neurotrophic factor Val66Met polymorphism and variation in human cortical morphology. J. Neurosci. 24 (2004) 10099-10102
19. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., Ernfors P., and Castren E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23 (2003) 349-357
20. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57 (2000) 925-935
21. Sapolsky R.M., Krey L.C., and McEwen B.S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7 (1986) 284-301
22. Scaccianoce S., Del Bianco P., Caricasole A., Nicoletti F., and Catalani A. Relationship between learning, stress and hippocampal brain-derived neurotrophic factor. Neuroscience 121 (2003) 825-828
23. Scharfman H.E., and MacLusky N.J. Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue?. Trends Neurosci. 28 (2005) 79-85
24. Seckl J.R., and Olsson T. Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect?. Endocrinol. 145 (1995) 201-211
25. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 93 (1996) 3908-3913
26. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15 (1995) 1768-1777
27. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napoletano B., Bilder R.M., Kane J.M., Goldman D., and Malhotra A.K. Brain-derived neurotrophic factor Val66Met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 10 (2005) 631-636
28. Tapia-Arancibia L., Rage F., Givalois L., and Arancibia S. Physiology of BDNF: focus on hypothalamic function. Front. Neuroendocrinol. 25 (2004) 77-107
29. Tuvnes F.A., Steffenach H.A., Murison R., Moser M.B., and Moser E.I. Selective hippocampal lesions do not increase adrenocortical activity. J. Neurosci. 23 (2003) 4345-4354
30. Ventriglia M., Bocchio Chiavetto L., Benussi L., Binetti G., Zanetti O., Riva M.A., and Pennarelli M. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol. Psychiatry 7 (2002) 136-137
31. Wolf O.T., Convit A., de Leon M.J., Caraos C., and Qadri S.F. Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: relationships to magnetic resonance imaging-derived hippocampus and cingulate gyrus volumes. Neuroendocrinology 75 (2002) 241-249
32. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., and Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression, a prospective study. J. Psychiatr. Res. 35 (2001) 83-94